Stay informed about INVO news, programming and initiatives, as well as Northwestern headlines related to innovation and entrepreneurship. You can also engage with us on Twitter (@NUatINVO).
Temprian Therapeutics accepted to S2STemprian Therapeutics will participate at the 2019 Science to Startup (S2S) symposium in Cambridge, Massachusetts. This invitation-only event on April 23 features twelve startups before an audience of 150+ pharmaceutical investors. Read more.
The Propel Program
Lakeside Discovery LLC LaunchedInvestment of up to $65 million will boost medical innovation at Northwestern. Read more about Lakeside Discovery launch.
The INVO newsletter, covering Northwestern's innovation and entrepreneurial activity across all disciplines, reaches the Northwestern University community, prospective licensees, investors, and others interested in groundbreaking research with commercialization potential.